NIH · NHLBI · SBIR PHASE II
XYLYX BIO, INC.
Translational development and clinical evaluation of a bioengineered human lung graft
Phase II plus explicit clinical-evaluation language creates a timely regulatory-planning conversation.
Fresh federal R&D funding signals
AwardCue turns new SBIR/STTR awards into ranked, evidence-linked lead briefs for regulatory, accounting, cyber, IP, and commercialization firms.
NIH · NHLBI · SBIR PHASE II
Translational development and clinical evaluation of a bioengineered human lung graft
Phase II plus explicit clinical-evaluation language creates a timely regulatory-planning conversation.
A real public signal, shown without exposing the contact detail included for subscribers.
The useful layer
Every brief is narrow enough to act on and cautious enough to trust. If nothing qualifies, we send nothing—volume never outranks fit.
New NIH and SBIR.gov awards are collected on a bounded schedule, with the original source preserved.
Freshness, phase, value, agency, geography, and service-specific language become hard filters and a transparent signal score.
You receive the company, funding event, public contact, why-now cue, caveats, and official link in email and CSV.
AWARDCUE / FDA + REGULATORY
10 qualified signalsPublic award intelligence · verify before outreachNo new dashboard
Built for specialist firms
Your feed is tuned to the work you actually sell—not a generic list resold to every consultant.
Clinical, diagnostic, therapeutic, device, and validation cues.
Defense, NASA, and DOE contract-style award signals.
Defense and security-sensitive scopes, always caveated.
Phase II transition, partner, and market-validation triggers.
Fresh invention-capture and freedom-to-operate moments.
Funded runway, hiring, reporting, and cash-planning signals.
What we will not pretend
01 Service cues are hypotheses. The award terms and company context remain authoritative.
02 Historical public contact details are labeled with their source date and should be re-verified.
03 AwardCue does not mass-message awardees. Subscribers control and review their own outreach.
Simple monthly plans
Start with five current signals matched to your service, geography, and minimum award size.
Founding pilot
One specialization, one weekly brief, up to 12 qualified signals per month.
Protected
One specialization in an agreed territory, delivered three times weekly.
Qualified volume varies with public award activity. We never pad a brief to meet a quota. Cancel before the next billing cycle.
Straight answers
No. The product is a filtered delivery service. You receive only new signals matched to the service and market you define.
Official public NIH RePORTER and SBIR.gov records. Every lead keeps a link back to the authoritative source.
No. A contact can come from a prior official award record. Its provenance is labeled so you can verify the person's present role before outreach.
No. That boundary prevents uncontrolled spam and keeps your relationship-building in your hands. We automate the research and delivery.
You receive an empty-run notice instead of weak leads. Filters can be adjusted, and monthly plans can be canceled before the next cycle.
Five signals. Your filters. No card.
Tell us your service, territory, and minimum award size. We'll reply with a current brief.